CR8843A - Derivados de 4-arilmorfolin-3-ona, su preparacion y su aplicacion en terapeutica - Google Patents
Derivados de 4-arilmorfolin-3-ona, su preparacion y su aplicacion en terapeuticaInfo
- Publication number
- CR8843A CR8843A CR8843A CR8843A CR8843A CR 8843 A CR8843 A CR 8843A CR 8843 A CR8843 A CR 8843A CR 8843 A CR8843 A CR 8843A CR 8843 A CR8843 A CR 8843A
- Authority
- CR
- Costa Rica
- Prior art keywords
- unsubstituted
- preparation
- arilmorfolin
- ona
- therapeutics
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/537—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines spiro-condensed or forming part of bridged ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Abstract
La invencion tiene por objeto compuestos qu eresponden a la formula ( I ) en la que Ar: representa un fenilo mono- o disustituido, R1 representa un fenilo no sustituido o sustituido; R2 representa un piridilo, un fenilo no sustuido o sustituido, un bencilo no sustituido o sustituido, un bencilo no sustituido sobre el fenilo, R2 puede ademas representar un radical heterociclico; R3 representa diferentes valores, procedimiento de preparacion y aplicacion en terapeutica
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0408222A FR2873373B1 (fr) | 2004-07-23 | 2004-07-23 | Derives de 4-arylmorpholin-3-one, leur preparation et leur application en therapeutique |
Publications (1)
Publication Number | Publication Date |
---|---|
CR8843A true CR8843A (es) | 2007-08-28 |
Family
ID=34951659
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR8843A CR8843A (es) | 2004-07-23 | 2007-01-09 | Derivados de 4-arilmorfolin-3-ona, su preparacion y su aplicacion en terapeutica |
Country Status (30)
Country | Link |
---|---|
US (1) | US7521449B2 (es) |
EP (1) | EP1773823B1 (es) |
JP (1) | JP4812759B2 (es) |
KR (1) | KR20070034066A (es) |
CN (1) | CN101006084B (es) |
AR (1) | AR050262A1 (es) |
AU (1) | AU2005276352A1 (es) |
BR (1) | BRPI0513581A (es) |
CA (1) | CA2573446A1 (es) |
CR (1) | CR8843A (es) |
EA (1) | EA011035B1 (es) |
EC (1) | ECSP077181A (es) |
FR (1) | FR2873373B1 (es) |
GT (1) | GT200500196A (es) |
HK (1) | HK1107340A1 (es) |
HN (1) | HN2005000380A (es) |
IL (1) | IL180484A0 (es) |
MA (1) | MA28741B1 (es) |
MX (1) | MX2007000814A (es) |
MY (1) | MY142757A (es) |
NO (1) | NO20071020L (es) |
PA (1) | PA8640101A1 (es) |
PE (1) | PE20060553A1 (es) |
SV (1) | SV2006002176A (es) |
TN (1) | TNSN06438A1 (es) |
TW (1) | TW200603800A (es) |
UA (1) | UA86082C2 (es) |
UY (1) | UY29022A1 (es) |
WO (1) | WO2006021654A1 (es) |
ZA (1) | ZA200700603B (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2912058A1 (fr) * | 2007-02-07 | 2008-08-08 | Sanofi Aventis Sa | Utilisation d'un compose antagoniste des recepteurs nk2 de la neurokinine a pour la preparation de medicaments utiles pour la prevention et le traitement des dysfonctions sexuelles |
US10314835B2 (en) | 2014-06-25 | 2019-06-11 | Emory University | Methods of managing conditioned fear with neurokinin receptor antagonists |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2729954B1 (fr) * | 1995-01-30 | 1997-08-01 | Sanofi Sa | Composes heterocycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant |
FR2751654B1 (fr) * | 1996-07-26 | 1998-10-23 | Sanofi Sa | Composes heterocycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant |
FR2738819B1 (fr) * | 1995-09-14 | 1997-12-05 | Sanofi Sa | Nouveaux composes antagonistes selectifs du recepteur nk3 humain, procede pour leur obtention et compositions pharmaceutiques les contenant |
RU2135494C1 (ru) * | 1995-12-01 | 1999-08-27 | Санкио Компани Лимитед | Гетероциклические соединения и композиция на их основе, проявляющая антагонистическое действие в отношении рецепторов тахикинина |
GB9601680D0 (en) * | 1996-01-27 | 1996-03-27 | Pfizer Ltd | Therapeutic agents |
JPH11240880A (ja) * | 1997-12-04 | 1999-09-07 | Sankyo Co Ltd | 脂環式アシル化複素環誘導体 |
PL341013A1 (en) * | 1997-12-04 | 2001-03-12 | Sankyo Co | Acylated heteroalicyclic derivatives |
GB9812037D0 (en) * | 1998-06-04 | 1998-07-29 | Pfizer Ltd | Piperidones |
FR2789390B3 (fr) * | 1999-02-10 | 2001-03-09 | Sanofi Sa | Nouveaux derives de piperidine, procede pour leur obtention et compositions pharmaceutiques les contenant |
FR2791346B3 (fr) * | 1999-03-25 | 2001-04-27 | Sanofi Sa | Nouveaux derives de morpholine, procede pour leur preparation et compositions pharmaceutiques les contenant |
JP2003522739A (ja) * | 1999-12-17 | 2003-07-29 | シェーリング コーポレイション | 選択的ニューロキニンアンタゴニスト |
FR2824828B1 (fr) * | 2001-05-21 | 2005-05-20 | Sanofi Synthelabo | Nouveaux derives de piperidinecarboxamide, un procede pour leur preparation et les compositions pharmaceutiques les contenant |
GB0130261D0 (en) * | 2001-12-18 | 2002-02-06 | Pfizer Ltd | Lactams as tachykinin antagonists |
-
2004
- 2004-07-23 FR FR0408222A patent/FR2873373B1/fr active Active
-
2005
- 2005-07-19 PE PE2005000833A patent/PE20060553A1/es not_active Application Discontinuation
- 2005-07-19 UY UY29022A patent/UY29022A1/es unknown
- 2005-07-20 EP EP05790796.6A patent/EP1773823B1/fr active Active
- 2005-07-20 KR KR1020077001501A patent/KR20070034066A/ko not_active Application Discontinuation
- 2005-07-20 WO PCT/FR2005/001852 patent/WO2006021654A1/fr active Application Filing
- 2005-07-20 JP JP2007521987A patent/JP4812759B2/ja not_active Expired - Fee Related
- 2005-07-20 CN CN2005800286192A patent/CN101006084B/zh not_active Expired - Fee Related
- 2005-07-20 UA UAA200701878A patent/UA86082C2/ru unknown
- 2005-07-20 MY MYPI20053337A patent/MY142757A/en unknown
- 2005-07-20 ZA ZA200700603A patent/ZA200700603B/xx unknown
- 2005-07-20 EA EA200700098A patent/EA011035B1/ru not_active IP Right Cessation
- 2005-07-20 GT GT200500196A patent/GT200500196A/es unknown
- 2005-07-20 BR BRPI0513581-8A patent/BRPI0513581A/pt not_active IP Right Cessation
- 2005-07-20 AU AU2005276352A patent/AU2005276352A1/en not_active Abandoned
- 2005-07-20 CA CA002573446A patent/CA2573446A1/fr not_active Abandoned
- 2005-07-20 MX MX2007000814A patent/MX2007000814A/es active IP Right Grant
- 2005-07-21 HN HN2005000380A patent/HN2005000380A/es unknown
- 2005-07-21 PA PA20058640101A patent/PA8640101A1/es unknown
- 2005-07-21 AR ARP050103016A patent/AR050262A1/es unknown
- 2005-07-22 SV SV2005002176A patent/SV2006002176A/es not_active Application Discontinuation
- 2005-07-22 TW TW094124977A patent/TW200603800A/zh unknown
-
2006
- 2006-12-26 TN TNP2006000438A patent/TNSN06438A1/fr unknown
-
2007
- 2007-01-01 IL IL180484A patent/IL180484A0/en unknown
- 2007-01-09 CR CR8843A patent/CR8843A/es unknown
- 2007-01-09 US US11/621,224 patent/US7521449B2/en not_active Expired - Fee Related
- 2007-01-17 EC EC2007007181A patent/ECSP077181A/es unknown
- 2007-01-17 MA MA29619A patent/MA28741B1/fr unknown
- 2007-02-22 NO NO20071020A patent/NO20071020L/no not_active Application Discontinuation
- 2007-11-22 HK HK07112751.7A patent/HK1107340A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR8824A (es) | Derivados de 2-carbamida-4-feniltiazol, su preparacion y su aplicacion en terapeutica | |
CY1119488T1 (el) | Παραγων για θεραπεια ή/και αποτροπη διαταραχης υπνου | |
NO20081846L (no) | Bifenylderivater og deres anvendelse ved behandling av hepatitt C | |
HN2008000130A (es) | Derivados de isoquinolona sustituidos con piperidinilo en calida de inhibidores de rho-quinasa | |
GT200600398A (es) | Compuestos de isoindol-imida y composiciones que los incluye y metodos para su uso | |
NZ596107A (en) | Antiviral compounds and methods | |
DOP2006000178A (es) | Derivados de isoquinolona sustituidos con piperidinilo | |
CR20120356A (es) | Nuevos compuestos heterocíclicos activos como inhibidores de beta-lactamasas | |
ATE346070T1 (de) | Purinderivate als kinaseinhibitoren | |
CR9602A (es) | Nuevos derivados de 2,4-dianilinpirimidinas, su preparacion, como medicamentos, composiciones farmaceuticas y particularmente como inhibidores de ikk | |
PA8683501A1 (es) | Derivados de isoquinolina | |
UY30105A1 (es) | Derivados nuevos azufrados de urea cíclica, su preparación y su utilización farmacéutica como inhibidores de quinasas. | |
UY29169A1 (es) | Derivados de 2-amido-4 feniltiazol, su preparacion y su aplicacion en terapeutica | |
ATE524181T1 (de) | Verwendung von 1,4-bis (3-aminoalkyl) piperazin- derivaten bei der behandlung von neurodegenerativen erkrankungen | |
UY29690A1 (es) | Derivados de n-(heteroaril)-1-heteroarilalquil-1h-indol-2-carboxamidas, su preparación y su aplicación en terapéutica. | |
NO20054340L (no) | Nye sammenkoplede heterocykler og deres anvendelse | |
NO20080265L (no) | 2-(1H-indolylsulfanyl)-arylaminderivater | |
EA200801366A1 (ru) | Производные 3,6-дигидро-2-оксо-6н-1,3,4-тиадиазина | |
CR9565A (es) | Derivados del 4,5-diarilpirrol, su preparacion y su aplicacion en terapeutica | |
NO20080839L (no) | Isotopsubstituerte protonpumpeinhibitorer | |
UY29054A1 (es) | Derivados de pirro, su preparación y su aplicación en terapeutica | |
CR8843A (es) | Derivados de 4-arilmorfolin-3-ona, su preparacion y su aplicacion en terapeutica | |
DK1644385T3 (da) | Siliciumforbindelser og deres anvendelse | |
NO20083352L (no) | 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav | |
DK1648906T3 (da) | Organo-silicium-forbindelser og deres anvendelse |